How to buy Monash IVF Group (MVF) shares
Learn how to easily invest in Monash IVF Group shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Monash IVF Group Limited is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Monash IVF Group has a trailing 12-month revenue of around $183.6 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Monash IVF Group
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Monash IVF Group. Find the share by name or ticker symbol: MVF. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Monash IVF Group reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Monash IVF Group. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Monash IVF Group key stats
- Compare share trading platforms
- Is Monash IVF Group stock a buy or sell?
- Monash IVF Group performance over time
- Are Monash IVF Group shares over-valued?
- Monash IVF Group's financials
- How volatile are Monash IVF Group shares?
- Does Monash IVF Group pay a dividend?
- Other common questions
Monash IVF Group stock price (ASX:MVF)Use our graph to track the performance of MVF stocks over time.
Monash IVF Group shares at a glance
|52-week range||$0.533 - $1.0084|
|50-day moving average||$0.9726|
|200-day moving average||$0.871|
|Dividend yield||$0.042 (4.31%)|
|Earnings per share (TTM)||$0.064|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Monash IVF Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Monash IVF Group price performance over time
|1 week (2021-09-17)||-2.01%|
|1 month (2021-08-25)||-2.01%|
|3 months (2021-06-25)||14.71%|
|6 months (2021-03-25)||28.29%|
|1 year (2020-09-25)||54.76%|
|2 years (2019-09-25)||-8.02%|
|3 years (2018-09-25)||-10.96%|
|5 years (2016-09-23)||-58.51%|
Is Monash IVF Group under- or over-valued?
Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Monash IVF Group's P/E ratio
Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Monash IVF Group shares trade at around 15x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Monash IVF Group's EBITDA
Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $38.2 million (£0.0 million).
The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure a its profitability.
Monash IVF Group financials
|Revenue TTM||$183.6 million|
|Operating margin TTM||18.52%|
|Gross profit TTM||$66.4 million|
|Return on assets TTM||6.07%|
|Return on equity TTM||9.79%|
|Market capitalisation||$379.9 million|
TTM: trailing 12 months
Monash IVF Group share dividends
Dividend payout ratio: 63.25% of net profits
Recently Monash IVF Group has paid out, on average, around 63.25% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.31% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 4.31% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.042 per share.
Monash IVF Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 8 September 2021 (the "ex-dividend date").
Monash IVF Group share price volatility
Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $0.533 up to $1.0084. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.8176. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Monash IVF Group overview
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility research and treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Richmond, Australia.
Stocks similar to Monash IVF Group
Monash IVF Group in the news
Monash IVF Group Limited (ASX:MVF) Stock Goes Ex-Dividend In Just Four Days
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert